Search

Search Results
Results 5461 - 5470 of 9450 for emergency medicine
  • Evotaz
    Drug - 12 Dec 2024
    Consumer Medicine Information (CMI) about Evotaz intended for persons living in Australia.
  • Arazil
    Drug - 12 Dec 2024
    Consumer Medicine Information (CMI) about Arazil intended for persons living in Australia.
  • New biomarker testing protocol could shorten antibiotic treatment for sepsis
    News - 10 Dec 2024
    A major UK patient trial of a new biomarker testing protocol for sepsis, led by University of Manchester researchers, has shown it is possible to safely stop antibiotic treatment earlier than current...
  • Symmetrel
    Drug - 9 Dec 2024
    Consumer Medicine Information (CMI) about Symmetrel intended for persons living in Australia.
  • Oxis Turbuhaler
    Drug - 6 Dec 2024
    Consumer Medicine Information (CMI) about Oxis Turbuhaler intended for persons living in Australia.
  • Bondronat
    Drug - 4 Dec 2024
    Consumer Medicine Information (CMI) about Bondronat intended for persons living in Australia.
  • Dasatinib Viatris
    Drug - 4 Dec 2024
    Consumer Medicine Information (CMI) about Dasatinib Viatris intended for persons living in Australia.
  • Voydeya
    Drug - 3 Dec 2024
    Consumer Medicine Information (CMI) about Voydeya intended for persons living in Australia.
  • Nplate
    Drug - 2 Dec 2024
    Consumer Medicine Information (CMI) about Nplate intended for persons living in Australia.
  • Aranesp
    Drug - 2 Dec 2024
    Consumer Medicine Information (CMI) about Aranesp intended for persons living in Australia.

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback